Wells Fargo & Company Absci Corp Transaction History
Wells Fargo & Company
- $429 Billion
- Q1 2025
A detailed history of Wells Fargo & Company transactions in Absci Corp stock. As of the latest transaction made, Wells Fargo & Company holds 48,537 shares of ABSI stock, worth $144,154. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,537
Previous 44,027
10.24%
Holding current value
$144,154
Previous $115,000
5.22%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ABSI
# of Institutions
144Shares Held
69MCall Options Held
361KPut Options Held
542K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10MShares$29.8 Million0.21% of portfolio
-
Redmile Group, LLC San Francisco, CA8.25MShares$24.5 Million2.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.45MShares$19.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.34MShares$15.9 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY4.29MShares$12.8 Million0.07% of portfolio
About Absci Corp
- Ticker ABSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 92,843,504
- Market Cap $276M
- Description
- Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....